Science in Sport plc
(the "Company")
Issue of Equity
and
Total Voting Rights
Science in Sport plc (AIM: SIS), the premium performance nutrition company serving elite athletes, sports enthusiasts, and the active lifestyle community, announces that a total of 9,852,866 ordinary shares of 10p each in the Company ("Ordinary Shares") have been issued and allotted in relation to the exercise of options in respect of the Company's LTIP scheme.
Application has been made to the London Stock Exchange for the admission of 9,852,866 new Ordinary Shares to trading on AIM. Admission is expected to take place at 8.00 am on 4 January 2024 and dealings in the shares will commence at that time.
The Company's total issued share capital immediately following admission will consist of 182,272,607 Ordinary Shares with one voting right per share. The above figure of 182,272,607 Ordinary Shares may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company following admission.
For further information:
| Science in Sport plc | T: 020 7400 3700 |
| Dan Wright, Executive Chairman Daniel Lampard, CFO
| |
| | |
| Liberum (Nominated Adviser and Broker) | T: 020 3100 2000 |
| Richard Lindley John More
| |
Notes to Editors
About Science in Sport plc
Headquartered in London, Science in Sport plc is a leading sports nutrition business that develops, manufactures, and markets innovative nutrition products for professional athletes, sports and fitness enthusiasts and the active lifestyle community. The Company has two highly regarded brands, PhD Nutrition, a premium active-nutrition brand targeting the active lifestyle community, and SiS, a leading endurance nutrition brand among elite athletes and professional sports teams.
The two brands sell through the Company's phd.com and scienceinsport.com digital platforms, third-party online sites, including Amazon and Tmall, and extensive retail distribution in the UK and internationally, including major supermarkets, high street chains and specialist sports retailers. This omnichannel footprint enables the Company to address the full breadth of the sports nutrition market, sports nutrition market, worth $24.6bn in 2022 and forecast to grow CAGR 5.9% from 2022 to 2027.1
SiS, a leading endurance nutrition business founded in 1992, has a core range comprising gels, powders and bars
focused on energy, hydration, and recovery. SiS is an official endurance nutrition supplier to over 320 professional teams, organisations, and national teams worldwide.
SiS is Performance Solutions partner to Ineos Grenadiers cycling team, Tottenham Hotspur and CGC Nice football, as well as Official Nutrition Partner to the Milwaukee Bucks, 2021 National Basketball Association Champions.
PhD is one of the UK's leading active nutrition brands with a reputation for high quality and product innovation. The brand has grown rapidly since its launch in 2005. The range now comprises powders, bars, and supplements, including the high protein, low sugar range, PhD Smart. PhD brand ambassadors include leading endurance and strength athlete Ross Edgley and influencer Gabby Allen.
For further information, please visit phd.com and scienceinsport.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.